Replies to post #647 on Biotech Values

[DewDiligence]

>> results from dyax phase 2 showed no change in lung function <<

LOL, no wonder DYAX did not mention lung function in yesterday’s PR. Nevertheless, the granting of orphan status makes DYAX’s drug a matter of consequence for GENR’s CF program.